Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPD1 | P10809 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL401412 | 0.87 | HSPD1 (0.37) | HSPD1BLMHSPE1 | |
| SCHEMBL28656014 | 0.68 | ALDH1A1 (0.37) | HSPD1BLMHSPE1 | |
| SCHEMBL891403 | 0.67 | HSPD1 (0.44) | HSPD1BLMHSPE1 | |
| SCHEMBL315984 | 0.67 | HSPD1 (0.44) | HSPD1BLMHSPE1 | |
| SCHEMBL15353035 | 0.67 | HSPD1 (0.34) | HSPD1BLMHSPE1 | |
| SCHEMBL30195 | 0.67 | HSPD1 (0.34) | HSPD1BLMHSPE1 | |
| SCHEMBL30016968 | 0.67 | HSPD1 (0.34) | HSPD1BLMHSPE1 | |
| SCHEMBL11460745 | 0.66 | HSPD1 (0.33) | HSPD1BLMHSPE1 | |
| SCHEMBL6251856 | 0.66 | HSPD1 (0.37) | HSPD1BLMHSPE1 | |
| SCHEMBL1122815 | 0.65 | HSPD1 (0.34) | HSPD1BLMHSPE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090124822-A1 | PROCESS FOR PREPARING MALATHION FOR PHARMACEUTICAL USE | TARO PHARMACEUTICALS NORTH AMERICA, INC. (KY) | 2009-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124822-A1 | PROCESS FOR PREPARING MALATHION FOR PHARMACEUTICAL USE | MSMO1, DDO, DCPS | HSPD1 2886/4885BLM 4037/4885HSPE1 2620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.